Skip to Content Skip to Content
Articles from Meagan Raeke
Learning I had Lynch syndrome ‘saved my life’
Dennis Massimo and his sister Lauren Massimo.

Dennis Massimo and his sister Lauren Massimo in 2026.

(Image: Courtesy of Penn Medicine News)

Learning I had Lynch syndrome ‘saved my life’

Dennis Massimo was only 42 and symptom-free when he was diagnosed with colorectal cancer, thanks to a research study he signed up for with the Penn Medicine BioBank nearly a decade earlier.

2 min. read

First CRISPR-based platform to pinpoint leukemia drivers
Rendering of a blood drop with a genetic DNA code inside.

Image: Alena Butusava via Getty Images

First CRISPR-based platform to pinpoint leukemia drivers

The new toolkit, developed by Penn Medicine and Children’s Hospital of Philadelphia, allows researchers to test potential cancer targets directly in patient leukemia cells.

2 min. read

New CAR T strategy targets most common form of heart disease
a close-up view of a coronary artery with cholesterol plaque signifying cardiovascular disease and atherosclerosis

Kateryna Kon/Science Photo Library via Getty Images

New CAR T strategy targets most common form of heart disease

Preclinical research from investigators at Penn Medicine shows that experimental CAR T cells block inflammation in arteries, preventing more than two-thirds of the plaque buildup seen in untreated controls.

2 min. read

Maximizing access to science with Penn Medicine’s Donita Brady
Donita Brady and three colleagues in an office.

Donita Brady (center), Harrison McCrea Dickson, M.D. and Clifford C. Baker, M.D. Presidential Professor.

(Image: Margo Reed)

Maximizing access to science with Penn Medicine’s Donita Brady

Brady, the 2026 recipient of the American Society for Biochemistry and Molecular Biology Ruth Kirschstein Award for Maximizing Access in Science, shares her approach to creating opportunities for all.

2 min. read

Enhanced CAR T cell therapy offers new strategy for lymphoma
3-D rendering of chimeric antigen receptor T (CAR-T) cell therapy, a treatment for a variety of cancers

Image: iStock/Naeblys

Enhanced CAR T cell therapy offers new strategy for lymphoma

A new study from Penn Medicine marks a significant development in the ongoing evolution of CAR T cell therapy, as a novel cytokine-enhanced CAR T that has been tested in patients with blood cancer shows robust response rates.

2 min. read

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

A preclinical study from the Perelman School of Medicine and Penn Medicine’s Abramson Cancer Center that combines RAS inhibition and immunotherapy shows promise for future clinical trials in pancreatic cancer treatment strategies.

1 min. read

Load More